Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

NTII

Neurobiological (NTII)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NTII
DataOraFonteTitoloSimboloCompagnia
07/12/200920:18Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NTIINeurobiological Technologies (MM)
07/12/200919:41Edgar (US Regulatory)-National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25)NASDAQ:NTIINeurobiological Technologies (MM)
23/11/200914:00PR Newswire (US)Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per ShareNASDAQ:NTII
16/11/200919:43Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:NTIINeurobiological Technologies (MM)
09/11/200922:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTIINeurobiological Technologies (MM)
28/10/200914:00PR Newswire (US)Neurobiological Technologies Announces Stockholder Approval of Plan of Liquidation and DissolutionNASDAQ:NTII
26/10/200919:00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NTIINeurobiological Technologies (MM)
26/10/200918:59Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:NTIINeurobiological Technologies (MM)
23/10/200923:19Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:NTIINeurobiological Technologies (MM)
19/10/200922:20PR Newswire (US)Neurobiological Technologies Announces Intent to File Form 25 to Delist Common Stock From the NASDAQ Capital MarketNASDAQ:NTII
22/09/200912:01Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:NTIINeurobiological Technologies (MM)
17/09/200923:00PR Newswire (US)Neurobiological Technologies Receives Nasdaq Closing Bid Price NotificationNASDAQ:NTII
08/09/200922:28Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:NTIINeurobiological Technologies (MM)
31/08/200922:27PR Newswire (US)Neurobiological Technologies Announces Board Approval of Plan of Liquidation and DissolutionNASDAQ:NTIINeurobiological Technologies (MM)
31/08/200922:14Edgar (US Regulatory)Annual Report (10-K)NASDAQ:NTIINeurobiological Technologies (MM)
12/08/200914:30PR Newswire (US)Neurobiological Technologies Announces Termination of its License and Cooperation Agreement with Merz and Children's Medical CenNASDAQ:NTIINeurobiological Technologies (MM)
01/06/200914:30PR Newswire (US)Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical ProgramNASDAQ:NTIINeurobiological Technologies (MM)
08/05/200913:00PR Newswire (US)Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial ResultsNASDAQ:NTIINeurobiological Technologies (MM)
01/05/200913:00PR Newswire (US)Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of MemantineNASDAQ:NTIINeurobiological Technologies (MM)
26/03/200912:30PR Newswire (US)Neurobiological Technologies Announces Hiring of Advisor to Seek Sale of CompanyNASDAQ:NTIINeurobiological Technologies (MM)
18/02/200912:02Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:NTIINeurobiological Technologies (MM)
12/02/200922:30PR Newswire (US)Neurobiological Technologies Reports Second Quarter Fiscal 2009 Financial ResultsNASDAQ:NTIINeurobiological Technologies (MM)
05/02/200922:17Edgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:NTIINeurobiological Technologies (MM)
04/02/200913:00PR Newswire (US)Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEONASDAQ:NTIINeurobiological Technologies (MM)
23/01/200912:02Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:NTIINeurobiological Technologies (MM)
13/01/200913:30PR Newswire (US)Neurobiological Technologies Announces Suspension of Viprinex DevelopmentNASDAQ:NTIINeurobiological Technologies (MM)
17/12/200813:00PR Newswire (US)Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility AnalysisNASDAQ:NTIINeurobiological Technologies (MM)
16/12/200814:00PR Newswire (US)Neurobiological Technologies' Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009NASDAQ:NTIINeurobiological Technologies (MM)
06/11/200812:30PR Newswire (US)Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial ResultsNASDAQ:NTIINeurobiological Technologies (MM)
05/11/200822:08Edgar (US Regulatory)Amended Securities Registration (section 12(g)) (8-A12G/A)NASDAQ:NTIINeurobiological Technologies (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NTII

La tua Cronologia

Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network